Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.51 |
| ▸ | RELA | Q04206 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | LPL | P06858 | 4/20 | 0.44 |
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12313750 | 1.00 | SMN1; SMN2 (0.51) | SMN1; SMN2NPC1NFKB1MAPK1RAB9A | |
| SCHEMBL12313746 | 1.00 | SMN1; SMN2 (0.51) | SMN1; SMN2NPC1NFKB1MAPK1RAB9A | |
| SCHEMBL13475015 | 1.00 | SMN1; SMN2 (0.51) | SMN1; SMN2NPC1NFKB1MAPK1RAB9A | |
| SCHEMBL10358431 | 1.00 | SMN1; SMN2 (0.51) | SMN1; SMN2NPC1NFKB1MAPK1RAB9A | |
| SCHEMBL1046903 | 1.00 | SMN1; SMN2 (0.51) | SMN1; SMN2NPC1NFKB1MAPK1RAB9A | |
| SCHEMBL753213 | 1.00 | SMN1; SMN2 (0.51) | SMN1; SMN2NPC1NFKB1MAPK1RAB9A | |
| SCHEMBL13475016 | 0.94 | NPC1 (0.55) | SMN1; SMN2NPC1NFKB1MAPK1RAB9A | |
| SCHEMBL12439871 | 0.94 | NPC1 (0.55) | SMN1; SMN2NPC1NFKB1MAPK1RAB9A | |
| SCHEMBL4911541 | 0.94 | NPC1 (0.55) | SMN1; SMN2NPC1NFKB1MAPK1RAB9A | |
| SCHEMBL15316152 | 0.93 | SMN1; SMN2 (0.46) | SMN1; SMN2NPC1NFKB1MAPK1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3416205-B1 | LIGHT-EMITTING ELEMENT AND METHOD FOR MANUFACTURING SAME | SUMITOMO CHEMICAL CO (JP) | 2021-03-17 | — | — | EP | disclosed |
| EP-2478981-B1 | SILVER-(CONJUGATED COMPOUND) COMPLEX | SUMITOMO CHEMICAL CO (JP) | 2020-12-23 | — | — | EP | disclosed |
| EP-3306694-B1 | LIGHT-EMITTING ELEMENT AND METHOD FOR MANUFACTURING SAME | SUMITOMO CHEMICAL CO (JP) | 2020-08-12 | — | — | EP | disclosed |
| EP-2687304-B1 | METAL COMPLEX COMPOSITIONS AND MIXTURE THEREOF | SUMITOMO CHEMICAL CO (JP) | 2019-01-23 | — | — | EP | disclosed |
| EP-3306694-A1 | LIGHT-EMITTING ELEMENT AND METHOD FOR MANUFACTURING SAME | Sumitomo Chemical Company, Ltd. (JP) | 2018-04-11 | — | — | EP | disclosed |
| US-9929347-B2 | Polymer compound and light emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) | 2018-03-27 | — | — | US | disclosed |
| US-9905767-B2 | High-molecular compound and light-emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-27 | — | — | US | disclosed |
| US-9853218-B2 | High-molecular compound and light-emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-12-26 | — | — | US | disclosed |
| US-9853218-B2 | High-molecular compound and light-emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-12-26 | — | — | US | disclosed |
| US-9780308-B2 | Composition and light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20110127517-A1 | COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| US-20110127516-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL COMPANY ,LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| US-20110006294-A1 | LAYERED STRUCTURE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-01-13 | — | — | US | disclosed |
| US-20110006294-A1 | LAYERED STRUCTURE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-01-13 | — | — | US | disclosed |
| US-20110006294-A1 | LAYERED STRUCTURE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-01-13 | — | — | US | disclosed |
| WO-2007071957-A1 | ELECTRONIC DEVICES WITH ARYL AMINE POLYMERS | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2007-06-28 | — | — | WO | disclosed |
| EP-1603963-A1 | POLYMERS, THEIR PREPARATION AND USES | Cambridge Display Technology Limited (GB) | 2005-12-14 | — | — | EP | disclosed |
| EP-1573789-A2 | ELECTROACTIVE POLYMERS | 3M Innovative Properties Company (US) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004102615-A2 | ELECTROACTIVE POLYMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004083277-A1 | POLYMERS, THEIR PREPARATION AND USES | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2004-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110127516-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | RER1, NAP1L1, CRY1 | SMN1; SMN2 1615/4885NPC1 3715/4885NFKB1 3199/4885 |
| US-20110127517-A1 | COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME | KCNMA1, KCNA1, KCNJ11 | SMN1; SMN2 1209/4885NPC1 1190/4885NFKB1 1447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.